Skip to main content
Nevis Brands Inc. logo

Nevis Brands Inc. — Investor Relations & Filings

Ticker · NEVI ISIN · CA64155A1066 CSE Manufacturing
Open in API
Filings indexed 417 across all filing types
Latest filing 2020-11-28 AGM Information
Country CA Canada
Listing CSE NEVI

About Nevis Brands Inc.

https://www.nevisbrands.com/

Nevis Brands Inc. is a consumer packaged goods company focused on developing and marketing cannabis beverages across the United States. The company operates in two primary segments: providing THC-infused drinks in state-regulated cannabis markets and offering hemp-derived THC beverages for nationwide distribution. Its portfolio of recreational brands includes Major™, a high-dose, top-selling beverage, and Happy Apple™. Nevis Brands leverages this dual market strategy to reach consumers both locally in regulated jurisdictions and nationally via hemp-derived products.

Recent filings

Filing Released Lang Actions
Notice of meeting - English.pdf
AGM Information Classification · 95% confidence The document is a Notice of Annual General and Special Meeting of Shareholders for Pascal Biosciences Inc. It outlines the agenda for the meeting, including receiving audited financial statements, appointing auditors, electing directors, and other shareholder matters. It also includes COVID-19 related attendance instructions and proxy voting information. The document is a formal notice inviting shareholders to the meeting rather than the meeting materials themselves or the results of the meeting. It does not contain financial statements or detailed reports but serves as an announcement of the meeting and its agenda. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting, including notices and agendas.
2020-11-28 English
News release - English.pdf
Regulatory Filings
2020-11-10 English
Notice of the meeting and record date (amended) - English.pdf
Regulatory Filings Classification · 95% confidence The document is a short notice from Computershare to Canadian Securities Regulatory Authorities regarding the upcoming Annual General and Special Meeting of Pascal Biosciences Inc. It provides details such as meeting type, record dates, meeting date, location, and proxy material delivery information. The document does not contain any financial data, management discussion, voting results, or detailed meeting materials. It is essentially an announcement about the meeting logistics and proxy material handling. Given the short length (1086 characters) and the nature of the content, this fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit other specific categories like AGM Information or Declaration of Voting Results. It is not a report or presentation itself, nor a voting result or proxy solicitation material.
2020-11-06 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of Pascal Biosciences Inc. It certifies the accuracy and fair presentation of the interim financial report and interim MD&A for the period ended August 31, 2020. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It references the interim filings but does not include them. According to the Certification Rule, such certification documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (2973 characters), consistent with a certification letter rather than a full report.
2020-11-02 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the CEO of Pascal Biosciences Inc. regarding the interim financial report and interim MD&A for the period ended August 31, 2020. It is a Form 52-109FV2 Venture Issuer Basic Certificate, which is an officer certification confirming the accuracy and fair presentation of the interim filings. The document does not contain actual financial data or substantive financial analysis but is a certification letter. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (2925 characters), consistent with a certification letter rather than a full report.
2020-11-02 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Consolidated Interim Financial Statements For the Nine Months Ended August 31, 2020 and 2019 Unaudited – Prepared by Management.' It contains detailed financial statements including statements of financial position, operations and comprehensive loss, changes in shareholders' equity, cash flows, and notes to the financial statements. The period covered is nine months, which is less than a full fiscal year, indicating an interim report. The document is unaudited and prepared in accordance with IAS 34 Interim Financial Reporting, confirming it is an interim financial report. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a full interim report, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2020
2020-11-02 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.